A Northwestern Medicine study provides new insights into the key role a molecule called oxPAPC plays in the inflammatory response. The findings could inform the development of new therapies for sepsis.
Immune cells migrating from the bloodstream to the brain may contribute to seizures in pediatric epilepsy, according to new findings published in the Journal of Experimental Medicine.
Antibodies that reverse immune system suppression may be able to be used to treat a rare type of melanoma, according to a Northwestern Medicine study published in the journal Nature.
The previously unknown cause of anti-phosphatidylethanolamine (aPE) autoimmunity was discovered in a Northwestern Medicine study published in PNAS.
The 2nd Annual Symposium on Sex Inclusion in Biomedical Research, held on the anniversary of the National Institutes of Health’s landmark sex-inclusion policy, highlighted research on sex bias in autoimmune diseases.
Northwestern Medicine scientists have demonstrated that tiny vesicles called exosomes released from non-metastatic melanoma cells trigger an immune response that prevents cancer from spreading throughout the body.
A new Northwestern Medicine study suggests that a protein called Bim may be a novel therapeutic target for lupus.
Research published in Proceedings of the National Academy of Sciences provides new insights into antibodies that block the Epstein-Barr virus from infecting human cells.
A Northwestern Medicine study analyzing the genomes of more than 27,000 individuals has uncovered that ethnic disparities in lupus diagnoses have a genetic basis.
A protein called POP2 inhibits a key inflammatory pathway, calming the body’s inflammatory response before it can become destructive, Northwestern Medicine scientists have found.